SpringerLink
Log in

Current Pathological and Clinical Aspects of Buerger’s Disease in Japan

  • General Review
  • Published:
Annals of Vascular Surgery

Abstract

Since Buerger’s disease was first described by Leo Buerger in 1908, many authors have discussed whether it indeed exists and, if so, is a definite clinical entity. Today, Buerger’s disease is accepted as a definite vascular disease with a typical clinical picture, natural history, and histopathology; however, the diagnosis of Buerger’s disease has been controversial, and the etiology of this vascular occlusive disease has remained unknown because many authors in different countries have their own criteria. Besides, patients with this disease have decreased in number even in Japan, while there has been no change in the number of arteriosclerosis obliterans patients. Currently, only one or two new patients per year are encountered at our outpatient clinic. The purpose of this review is to examine the current epidemiological, pathological, and clinical aspects of Buerger’s disease in Japan based on the 222 patient files of our department between 1980 and 2000 and to discuss the pathogenesis, clinical presentation, and various treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Adar R, Papa MZ, Halpern Z, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N. Engl. J. Med 1983;308:1113-1116

    Article  PubMed  CAS  Google Scholar 

  2. Eichhorn J, Sima D, Lindschau C, et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am. J. Med. Sci 1998;315:17-23

    PubMed  CAS  Google Scholar 

  3. Lee T, Seo J-T, Sumpio BE, et al. Immunologic analysis of arterial tissue in Buerger’s disease. Eur. J. Endovasc. Surg 2003;25:451-457

    CAS  Google Scholar 

  4. Kobayashi M, Kurose K, Kobata T, Hida K, Sakamoto S, Matsubara J. Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review. J. Vasc. Surg 2003;38:170-174

    Article  PubMed  Google Scholar 

  5. Winiwater F. Uber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangan des Fusses. Arch. Klin. Chir 1878;23:202-226

    Google Scholar 

  6. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am. J. Med. Sci 1908;136:567-580.

    Google Scholar 

  7. Wessler S, Ming SC, Gurewich V, Freiman DG. A critical evaluation of thromboangiitis obliterans. The case against Buerger’s disease. N. Engl. J. Med 1960;262:1149-1162

    Article  PubMed  CAS  Google Scholar 

  8. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger’s disease). Acta Pathol. Jpn 1989;39:153-157

    PubMed  CAS  Google Scholar 

  9. Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger’s disease). In: Goldstone J (ed), Perspectives in Vascular Surgery, vol. 5. St Louis: Quality Medical Publishing, 1992. pp 1-21

    Google Scholar 

  10. Shionoya S. Pathology. In: Shionoya S (ed), Buerger’s Disease. Nagoya: University of Nagoya Press, 1990, pp 57-79.

    Google Scholar 

  11. McKusick VA. Buerger’s disease: a distinct clinical and pathologic entity. J.A.M.A 1962;181:93-100

    Google Scholar 

  12. Adar R. Buerger’s disease - the need for diagnostic criteria. Surgery 1974;76:848

    PubMed  CAS  Google Scholar 

  13. Shionoya S. Diagnostic criteria of Buerger’s disease. Int. J. Cardiol 1998;66(Suppl 1):243-245

    Google Scholar 

  14. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger’s disease in Japan. Surgery 1998;124:498-502

    PubMed  Google Scholar 

  15. Shionoya S. What is Buerger’s disease? World J. Surg 1983;7:544-551.

    CAS  Google Scholar 

  16. Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger’s disease (endarteritis obliterans). J. Vasc. Surg 1999;29:451-458

    Article  PubMed  CAS  Google Scholar 

  17. Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum. Dis. Clin. North Am 1990;16:269-292

    PubMed  CAS  Google Scholar 

  18. Shionoya S. Buerger’s disease (thromboangiitis obliterans). In: Rutherford RB (ed), Vascular Surgery, 4th ed. Philadelphia: WB Saunders, 1995, pp 235-45

    Google Scholar 

  19. Matsushita M, Kuzuya A, Kobayashi K, et al. Buerger’s disease in a 19-year-old woman. J. Vasc. Surg 2003;38:175-179

    Article  PubMed  Google Scholar 

  20. Foliart D, Benowitz NL, Becker CE. Passive absorption of nicotine in airline flight attendants. N. Engl. J. Med 1983;308:1105

    Article  PubMed  CAS  Google Scholar 

  21. Mattson ME, Boyd G, Byar D, et al. Passive smoking on commercial airline flights. J.A.M.A 1989;261:867-872

    Article  PubMed  CAS  Google Scholar 

  22. Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurement in patients with Buerger’s disease - effects of active and passive smoking on the disease process. J. Vasc. Surg 1991;14:53-58

    PubMed  CAS  Google Scholar 

  23. Nishikimi N. Fate of limbs with failed vascular reconstruction in Buerger’s disease patients. Int. J. Cardiol 2000;75:183-185

    Article  Google Scholar 

  24. Corelli F. Buerger’s disease: cigarette smoker disease may always be cured by medical therapy alone. Uselessness of operative treatment. J. Cardiovasc. Surg 1973;14:28-36

    CAS  Google Scholar 

  25. de Takats G. Diagnosis and management of Buerger’s disease. Postgrad. Med 1948;3:185-191

    Google Scholar 

  26. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum. Dis. Clin. North Am 2001;27:729-749.

    PubMed  CAS  Google Scholar 

  27. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitides. Best Pract. Res. Clin. Rheumatol 2002;16:833-845

    PubMed  Google Scholar 

  28. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr. Opin. Rheumatol 2003;15:11-16

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Masayoshi Kobayashi MD, PhD, Naomichi Nishikimi MD, PhD & Kimihiro Komori MD, PhD

  2. Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, 466-8550, Nagoya, Japan

    Masayoshi Kobayashi MD, PhD

Authors
  1. Masayoshi Kobayashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naomichi Nishikimi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kimihiro Komori MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masayoshi Kobayashi MD, PhD.

About this article

Cite this article

Kobayashi, M., Nishikimi, N. & Komori, K. Current Pathological and Clinical Aspects of Buerger’s Disease in Japan. Ann Vasc Surg 20, 148–156 (2006). https://doi.org/10.1007/s10016-005-9436-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10016-005-9436-2

Keywords

Search

Navigation